NRX Pharmaceuticals, Inc. Notes Payable, Current
NRX Pharmaceuticals, Inc. (NRXP) had Notes Payable, Current of $500.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2022-05-16
- 2022-03-31: Notes Payable, Current $500.00K.
- 2021-12-31: Notes Payable, Current $500.00K.
- 2021-03-31: Notes Payable, Current $1.97M.
- 2020-12-31: Notes Payable, Current $1.81M.
| Period end | Notes Payable, Current |
|---|---|
| 2022-03-31 | $500.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $500.00K 10-Q · filed 2022-05-16 |
| 2021-03-31 | $1.97M 10-Q · filed 2021-05-21 |
| 2020-12-31 | $1.81M 10-Q · filed 2021-05-21 |
| 2019-12-31 | $1.54M 10-K/A · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |